Login / Signup
Susan Kreissman
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 3
Top Topics
Cell Therapy
Clinical Trial
Chronic Kidney Disease
Copy Number
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Navin R Pinto
,
Arlene Naranjo
,
Xiangming Ding
,
Fan F Zhang
,
Emily Hibbitts
,
Rebekah Kennedy
,
Rachelle Tibbetts
,
Shannon Wong-Michalak
,
David W Craig
,
Zarko Manojlovic
,
Michael D Hogarty
,
Susan Kreissman
,
Rochelle Bagatell
,
Meredith S Irwin
,
Julie R Park
,
Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Navin R Pinto
,
Arlene Naranjo
,
Xiangming Ding
,
Fan F Zhang
,
Emily Hibbitts
,
Rebekah Kennedy
,
Rachelle Tibbetts
,
Shannon Wong-Michalak
,
David W Craig
,
Zarko Manojlovic
,
Michael D Hogarty
,
Susan Kreissman
,
Rochelle Bagatell
,
Meredith S Irwin
,
Julie R Park
,
Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)
Navin R Pinto
,
Arlene Naranjo
,
Xiangming Ding
,
Fan F Zhang
,
Emily Hibbitts
,
Rebekah Kennedy
,
Rachelle Tibbetts
,
Shannon Wong-Michalak
,
David W Craig
,
Zarko Manojlovic
,
Michael D Hogarty
,
Susan Kreissman
,
Rochelle Bagatell
,
Meredith S Irwin
,
Julie R Park
,
Shahab Asgharzadeh
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology without MYCN Amplification.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)